BE PART OF THE GROWING JOURNEY OF DMFR

DMFR Premier Diagnostics Service Provider known for its advance state-of- art Technology, Quality & Service driven Medical Care. DMFR aims to become National Network of Highly Automated and Sophisticated Laboratory with Accuracy, Quality, Technology, Standards, Ethics and Customer Satisfaction. DMFR Diagnostics has focused on introducing the latest technology in Laboratory Testing e.g.  First time in private sector BSL-3 facility with Molecular Diagnostics, and complete range of Oncology Investigations with Flow Cytometry. DMFR offers Multi-disciplinary International Standard Compliant Diagnostic facility at Dhaka

INVITES APPLICATION FOR FOLLOWING VACCANCIES
  1. Biochemistry Lab Technician
  2. Histopathology Technician
  3. Phlebotomy Technician
  4. Cardio Technician (ECG, ECHO & ETT)
  5. Senior Scientific Officer (Molecular Diagnostics Lab)
  6. X-Ray Technician

Comprehensive Benefits at DMFR

Prospect to make a very good progressive career with us. Working environment complying International Processes. Benefits are an important part of our commitment to our employees. Full-time employees qualify for a variety of benefits, including:      

  • Employee Career Growth Planning.
  • Comprehensive subsidized medical plans for employees and their family Various In-House and Outside Training Programs on merit basis
  • Attractive Salary
  • Job Satisfaction
  • Tax-advantaged Reimbursements       
  • Life and Accidental Death Insurance

Application from aspiring candidates for above mentioned vacancies should send their resume at following address physically or send email at hr.dmfr1234@gmail.com. Managing Director, DMFR Molecular Lab Bangladesh Ltd., Corporate Office: Sima Blossom (11th Floor), H#3, R#16, Dhanmondi, Dhaka-1205, Bangladesh.

  • Training will be provided for improving skills
  • The position applied for must be mentioned in the subject line of your mail.
  • DMFR Molecular Lab Bangladesh Ltd. Is an Equal Employment Opportunity provider.

Application Deadline: 15th February 2019